Healthway Medical Corporation Limited announced unaudited earnings results for the fourth quarter and full year ended December 31, 2016. For the quarter, the company reported revenue was SGD 23,377,000 against revenue of SGD 23,328,000 a year ago. Loss before income tax was SGD 41,054,000 against loss before income tax of SGD 1,229,000 a year ago. Loss for the period attributable to shareholders was SGD 40,859,000 against loss for the period attributable to shareholders of SGD 904,000 a year ago. Net cash generated from operating activities was SGD 706,000 against net cash generated from operating activities of SGD 79,000 a year ago. Addition to property, plant and equipment was SGD 56,000. Basic and diluted loss per ordinary share was 1.66 cents against 0.04 cents a year ago.

For the full year, the company reported revenue was SGD 96,751,000 against revenue of SGD 94,273,000 a year ago. Loss before income tax was SGD 40,340,000 against profit before income tax of SGD 2,696,000 a year ago. Loss for the period attributable to shareholders was SGD 40,155,000 against profit for the period attributable to shareholders of SGD 1,683,000 a year ago. Net cash generated from operating activities was SGD 3,960,000 against net cash generated from operating activities of SGD 10,815,000 a year ago. Addition to property, plant and equipment was SGD 328,000 against addition to property, plant and equipment of SGD 658,000 a year ago. Addition to intangible assets was SGD 1,000. Basic and diluted loss per ordinary share was 1.71 cents against basic and diluted earnings per ordinary share of 0.07 cents a year ago. Net asset value per ordinary share was 6.34 cents compared to 8.31 cents a year ago. LBITDA was SGD 37,398,000 compared to EBITDA of SGD 3,603,000 a year ago.

For the fourth quarter Ended December 31, 2016, the company reported Impairment of goodwill SGD 3,000.